CA2587780A1 — Combined micro-channel generation and iontophoresis for transdermal delivery of pharmaceutical agents
Assigned to Syneron Medical Ltd · Expires 2006-05-26 · 20y expired
What this patent protects
The present invention relates to methods of transdermal delivery of pharmaceutical agents. In particular, the present invention relates to a method for transdermal delivery comprising generating micro-channels on the skin of a subject and delivering iontophoretically a pharmaceut…
USPTO Abstract
The present invention relates to methods of transdermal delivery of pharmaceutical agents. In particular, the present invention relates to a method for transdermal delivery comprising generating micro-channels on the skin of a subject and delivering iontophoretically a pharmaceutical agent through the micro-channels. The method provides synergistic transdermal delivery of pharmaceutical agents. .
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.